LncRNAs could serve as potential predictive and prognosis markers for EGFR resistant and mutant lung cancers as, they have been implicated in the regulation of chemosensitivity, radiosensitivity, and sensitivity of EGFR targeted therapies in lung cancers through diverse mechanisms [25]. This evidence concerns the gene EGFR and lung carcinoma.